Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Pharma News, Views & Analysis
Filter
News
Articles
Podcasts
Infographics
Advertise With Us
Advertise With Us
Daiichi Sankyo's Dr Michael Zaiac on moving beyond 'sick care'
Daiichi Sankyo’s Dr Michael Zaiac discusses how AI, biomarkers and targeted therapies are shaping oncology.
Read more
Mastering medical affairs
Medical affairs is becoming increasingly complex, but industry-academia collaboration aims to tackle this head on.
The brains behind neurological breakthroughs
The recent approval of lecanemab is a win for Alzheimer’s patients, but how can pharma ensure access?
Pharma in Poland
Travel to Poland to discover the factors driving its pharmerging status and access to medicine challenges.
Reflections and predictions for 2023
Explore the key trends and themes industry experts predict will be in store for pharma over the next 12 months.
Mental health matters in pharma's approach to care
Treatments for cancer are continuously advancing, but pharma must also focus on supporting patients’ mental health.
Utilising data lakes in pharma
Pharma’s data lake is increasing in size. Read to find out how the industry can use it to its best advantage.
A blockchain solution for pharma
How can blockchain-based technology advance business development and investment?
5 minutes with Gen Li, President, Phesi
5 minutes with Gen Li, President of clinical trial database company Phesi.
Loading posts...
« Previous
1
…
11
12
13
14
15
…
35
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View